arrow
A

Anna Rull

institut de recerca biomedica catalunya sud
H指数:30
被引数:3,453

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early antiretroviral therapy shapes the immunometabolic landscape without reducing the intact HIV reservoir

早期抗逆转录病毒治疗重塑免疫代谢景观,但不减少完整的HIV储库

2026-04-280
OAAI
Metabolomics for searching non-invasive biomarkers of metabolic dysfunction-associated steatotic liver disease in youth with vertical HIV

代谢组学用于寻找垂直HIV感染青少年中代谢功能障碍相关脂肪性肝病的无创生物标志物

2025-10-230
OA
Unveiling altered CD8 T-cell metabolism and homeostatic proliferation behind a low CD4/CD8 ratio in ART-suppressed HIV individuals with normal CD4 recovery

揭示ART抑制的HIV感染者中正常CD4恢复背景下低CD4/CD8比率背后的CD8 T细胞代谢异常和稳态增殖

2025-09-080
OA
Deciphering long-term immune effects of HIV-1/SARS-CoV-2 co-infection: a longitudinal study (vol 214, 4, 2024)

解析HIV-1/SARS-CoV-2混合感染的长期能免疫效应:一项纵向研究(卷214,4,2024)

2025-05-060
OAAI
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

持久性精英控制器和瞬态精英控制器中的HIV-1水库景观

2024-02-204
OAAI
Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes

循环丙酮酸是关键新型冠状病毒肺炎结局的有效预后标志物

2022-09-1414
OAAI
Elevated α-Ketoglutaric Acid Concentrations and a Lipid-Balanced Signature Are the Key Factors in Long-Term HIV Control

Α-酮戊二酸浓度升高和脂质平衡特征是长期HIV控制的关键因素

2022-04-203
OAAI
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

胎蛋白A、间 α-胰蛋白酶抑制剂、谷氨酸和ChoE (18:0) 是区分轻度和危重冠状病毒疾病2019结局的关键生物标志物

2022-01-2410
OA
Differential miRNA plasma profiles associated with the spontaneous loss of HIV-1 control: miR-199a-3p and its potential role as a biomarker for quick screening of elite controllers
2021-07-043
OAAI
Epigenome-wide association study of COVID-19 severity with respiratory failure

新型冠状病毒肺炎严重程度与呼吸衰竭的表观基因组关联研究

2021-04-0191
OAAI